Yoshihide Suga Requests Pfizer To Supply Additional CCP Virus Vaccine to Japan
- Editor: Ranting
Japanese Prime Minister Yoshihide Suga held a telephone conversation with Albert Bourla, chief executive officer (CEO) of the U.S. drug company Pfizer, in Washington, D.C., on the morning of April 17 local time. Suga requested Pfizer to supply additional CCP virus vaccine to Japan.
Information released by the Japanese government shows that Suga made the request in order to ensure that the vaccine would be available to all Japanese people by September. Bourla responded that “we will move forward quickly with the consultations and work closely with the Japanese government”.
Suga also expressed his gratitude to Pfizer for supplying the vaccine to Japan. The call lasted about 10 minutes.
The Japanese government has signed an agreement with Pfizer to supply 144 million doses (72 million doses) of the CCP virus vaccine over 2021. Pfizer’s vaccine was approved in Japan in February and is now the only CCP virus vaccine available in Japan.
In addition to Pfizer, vaccines from AstraZeneca (UK) and Moderna (US), which have signed vaccine supply agreements with Japan, have not yet been approved in Japan.